Actively Recruiting
Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
Led by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Updated on 2025-07-01
400
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
Sponsors
D
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead Sponsor
C
Children's Hospital of Chongqing Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
In preterm infants with neonatal respiratory distress syndrome (NRDS), exogenous pulmonary surfactant(PS) replacement therapy is one of the most important therapeutic breakthrough to reduce neonatal mortality. Nowadays, PS is commonly used in newborn infants with respiratory distress, but the incidences of bronchopulmonary dysplasia(BPD) and/or death are inconsistent. The result indicates that not all preterm infants with respiratory distress can be beneficial from PS. In 2017, the international neonatal ARDS (NARDS) collaborative group provides the first consensus definition for NARDS. And whether or not PS being beneficial for preterm infants with NARDS remains unknown.
CONDITIONS
Official Title
Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Gestational age less than 37 weeks and admitted to neonatal intensive care unit (NICU) within 24 hours after birth
- Diagnosed with neonatal respiratory distress syndrome (NRDS) or neonatal acute respiratory distress syndrome (NARDS)
- Will receive at least one dose of surfactant replacement therapy
You will not qualify if you...
- Major congenital anomalies
- Chromosomal abnormalities
- Upper respiratory tract abnormalities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chen
Chongqing, Chongqing Municipality, China, 400042
Actively Recruiting
Research Team
C
Chen Long, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here